Purple Biotech Stock Performance
| PPBT Stock | USD 0.60 0.02 2.58% |
The company holds a Beta of -0.014, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Purple Biotech are expected to decrease at a much lower rate. During the bear market, Purple Biotech is likely to outperform the market. At this point, Purple Biotech has a negative expected return of -0.5%. Please make sure to check Purple Biotech's potential upside, as well as the relationship between the kurtosis and day typical price , to decide if Purple Biotech performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Purple Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental drivers remain comparatively stable which may send shares a bit higher in March 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Last Split Factor 1:20 | Dividend Date 2020-08-21 | Last Split Date 2024-09-17 |
1 | Will Purple Biotech Ltd stock extend growth story - Weekly Earnings Recap AI Powered BuySell Recommendations - newser.com | 11/11/2025 |
2 | Purple Biotech GAAP EPADS of -0.86 | 11/14/2025 |
3 | Why Purple Biotech Ltd Depositary Receipt stock is considered a top pick - Layoff News Accurate Buy Signal Notifications - newser.com | 11/19/2025 |
4 | Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology 2025 ... | 12/04/2025 |
5 | Trend Report What is Purple Biotech Ltd Depositary Receipts market position - 2025 Risk Factors Weekly Top Performers Watchlists - baoquankhu1.vn | 01/26/2026 |
| Begin Period Cash Flow | 14.5 M | |
| Total Cashflows From Investing Activities | 509 K |
Purple Biotech Relative Risk vs. Return Landscape
If you would invest 86.00 in Purple Biotech on November 1, 2025 and sell it today you would lose (25.60) from holding Purple Biotech or give up 29.77% of portfolio value over 90 days. Purple Biotech is currently does not generate positive expected returns and assumes 3.9708% risk (volatility on return distribution) over the 90 days horizon. In different words, 35% of stocks are less volatile than Purple, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Purple Biotech Target Price Odds to finish over Current Price
The tendency of Purple Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.60 | 90 days | 0.60 | more than 94.0 |
Based on a normal probability distribution, the odds of Purple Biotech to move above the current price in 90 days from now is more than 94.0 (This Purple Biotech probability density function shows the probability of Purple Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Purple Biotech has a beta of -0.014 indicating as returns on the benchmark increase, returns on holding Purple Biotech are expected to decrease at a much lower rate. During a bear market, however, Purple Biotech is likely to outperform the market. Additionally Purple Biotech has an alpha of 0.5169, implying that it can generate a 0.52 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Purple Biotech Price Density |
| Price |
Predictive Modules for Purple Biotech
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Purple Biotech. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Purple Biotech Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Purple Biotech is not an exception. The market had few large corrections towards the Purple Biotech's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Purple Biotech, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Purple Biotech within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.52 | |
β | Beta against Dow Jones | -0.01 | |
σ | Overall volatility | 0.09 | |
Ir | Information ratio | 0.04 |
Purple Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Purple Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Purple Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Purple Biotech generated a negative expected return over the last 90 days | |
| Purple Biotech has some characteristics of a very speculative penny stock | |
| Purple Biotech has high historical volatility and very poor performance | |
| Net Loss for the year was (7.28 M) with loss before overhead, payroll, taxes, and interest of (62 K). | |
| Purple Biotech currently holds about 36.02 M in cash with (14.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.0, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from news.google.com: Trend Report What is Purple Biotech Ltd Depositary Receipts market position - 2025 Risk Factors Weekly Top Performers Watchlists - baoquankhu1.vn |
Purple Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Purple Stock often depends not only on the future outlook of the current and potential Purple Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Purple Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.6 M | |
| Cash And Short Term Investments | 8.5 M |
Purple Biotech Fundamentals Growth
Purple Stock prices reflect investors' perceptions of the future prospects and financial health of Purple Biotech, and Purple Biotech fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Purple Stock performance.
| Return On Equity | -0.0856 | ||||
| Return On Asset | -0.1 | ||||
| Current Valuation | (3.79 M) | ||||
| Shares Outstanding | 9.03 M | ||||
| Price To Book | 0.17 X | ||||
| Price To Sales | 58.08 X | ||||
| Gross Profit | (62 K) | ||||
| EBITDA | (7.05 M) | ||||
| Net Income | (7.28 M) | ||||
| Cash And Equivalents | 36.02 M | ||||
| Cash Per Share | 2.00 X | ||||
| Total Debt | 183 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 6.94 X | ||||
| Book Value Per Share | 0.06 X | ||||
| Cash Flow From Operations | (14.37 M) | ||||
| Earnings Per Share | (45.90) X | ||||
| Market Capitalization | 6.77 M | ||||
| Total Asset | 37.04 M | ||||
| Retained Earnings | (144.69 M) | ||||
| Working Capital | 4.92 M | ||||
About Purple Biotech Performance
Assessing Purple Biotech's fundamental ratios provides investors with valuable insights into Purple Biotech's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Purple Biotech is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | -6.1 M | -6.4 M | |
| Return On Tangible Assets | (0.71) | (0.74) | |
| Return On Capital Employed | (0.30) | (0.31) | |
| Return On Assets | (0.20) | (0.18) | |
| Return On Equity | (0.20) | (0.21) |
Things to note about Purple Biotech performance evaluation
Checking the ongoing alerts about Purple Biotech for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Purple Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Purple Biotech generated a negative expected return over the last 90 days | |
| Purple Biotech has some characteristics of a very speculative penny stock | |
| Purple Biotech has high historical volatility and very poor performance | |
| Net Loss for the year was (7.28 M) with loss before overhead, payroll, taxes, and interest of (62 K). | |
| Purple Biotech currently holds about 36.02 M in cash with (14.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.0, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from news.google.com: Trend Report What is Purple Biotech Ltd Depositary Receipts market position - 2025 Risk Factors Weekly Top Performers Watchlists - baoquankhu1.vn |
- Analyzing Purple Biotech's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Purple Biotech's stock is overvalued or undervalued compared to its peers.
- Examining Purple Biotech's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Purple Biotech's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Purple Biotech's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Purple Biotech's stock. These opinions can provide insight into Purple Biotech's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Purple Stock Analysis
When running Purple Biotech's price analysis, check to measure Purple Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Purple Biotech is operating at the current time. Most of Purple Biotech's value examination focuses on studying past and present price action to predict the probability of Purple Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Purple Biotech's price. Additionally, you may evaluate how the addition of Purple Biotech to your portfolios can decrease your overall portfolio volatility.